
|Articles|July 1, 2004
AMO to work with Quest Vision on presbyopic IOLs
Santa Ana, CA-Advanced Medical Optics Inc. (AMO) has forged a 1-year research and evaluation licensing agreement with Quest Vision Technologies Inc. to develop accommodating IOL designs. Under the agreement, which was announced May 3, AMO will own a minority interest in Quest Vision, with an option to buy the company after 1 year.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025: Early optogenetic therapy shows promise for patients with inherited retinal diseases
2
Subretinal drusenoid deposits in Black and Hispanic patients with AMD
3
Starting from scratch on neovascular age-related macular degeneration
4
Throwback Series: Identifying and treating neovascular lesions in pregnancy
5